MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202611000685 A) filed by Garima Chauhan; Dr. Sahil Kumar; Dr. D. P. Pathak; Pragya Dubey; Deepak Kumar; and Md. Azhar Iqbal, New Delhi, on Jan. 4, for 'novel quinazolinone-benzoxazolinone and phthalimide hybrids as potent vegfr-2 inhibitors for breast cancer therapy.'
Inventor(s) include Garima Chauhan; Dr. Sahil Kumar; Dr. D. P. Pathak; Pragya Dubey; Deepak Kumar; and Md. Azhar Iqbal.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel quinazoline/quinazolinone-based hybrid compounds useful as anticancer agent...